286 related articles for article (PubMed ID: 31657174)
21. Non-communicable disease governance in the era of the sustainable development goals: a qualitative analysis of food industry framing in WHO consultations.
Lauber K; Ralston R; Mialon M; Carriedo A; Gilmore AB
Global Health; 2020 Aug; 16(1):76. PubMed ID: 32847604
[TBL] [Abstract][Full Text] [Related]
22. Corporate power and the international trade regime preventing progressive policy action on non-communicable diseases: a realist review.
Milsom P; Smith R; Baker P; Walls H
Health Policy Plan; 2021 May; 36(4):493-508. PubMed ID: 33276385
[TBL] [Abstract][Full Text] [Related]
23. The double burden of neoliberalism? Noncommunicable disease policies and the global political economy of risk.
Glasgow S; Schrecker T
Health Place; 2016 May; 39():204-11. PubMed ID: 27132687
[TBL] [Abstract][Full Text] [Related]
24. Lessons from the Field: Interventions to Improve Health and Quality of Life to Address the NCD Crisis in Palau - Fostering Collaboration Across Sectors within the Government and Civil Society.
Ikerdeu E; Lyman A; Koshiba C; Tutii I; Whipps V; Ngirmang K; Osarch S
Hawaii J Health Soc Welf; 2020 Jun; 79(6 Suppl 2):19-23. PubMed ID: 32596673
[TBL] [Abstract][Full Text] [Related]
25. The state of diet-related NCD policies in Afghanistan, Bangladesh, Nepal, Pakistan, Tunisia and Vietnam: a comparative assessment that introduces a 'policy cube' approach.
Buse K; Aftab W; Akhter S; Phuong LB; Chemli H; Dahal M; Feroz A; Hofiani S; Pradhan NA; Anwar I; Skhiri HA; El Ati J; Giang KB; Puri M; Noormal B; Rabbani F; Hawkes S
Health Policy Plan; 2020 Jun; 35(5):503-521. PubMed ID: 32091080
[TBL] [Abstract][Full Text] [Related]
26. Governing Noncommunicable Diseases Through Political Rationality and Technologies of Government: A Discourse Analysis.
Yang JS; Mamudu HM; Mackey TK
Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575474
[TBL] [Abstract][Full Text] [Related]
27. Assessing the association between Corporate Financial Influence and implementation of policies to tackle commercial determinants of non-communicable diseases: A cross-sectional analysis of 172 countries.
Allen LN; Wigley S; Holmer H
Soc Sci Med; 2022 Mar; 297():114825. PubMed ID: 35228150
[TBL] [Abstract][Full Text] [Related]
28. Baseline status of policy and legislation actions to address non communicable diseases crisis in the Pacific.
Win Tin ST; Kubuabola I; Ravuvu A; Snowdon W; Durand AM; Vivili P; Passmore E
BMC Public Health; 2020 May; 20(1):660. PubMed ID: 32398159
[TBL] [Abstract][Full Text] [Related]
29. Intersectoral Action for Addressing NCDs through the Food Environment: An Analysis of NCD Framing in Global Policies and Its Relevance for the African Context.
Weimann A; Shung-King M; McCreedy N; Tatah L; Mapa-Tassou C; Muzenda T; Govia I; Were V; Oni T
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769763
[TBL] [Abstract][Full Text] [Related]
30. Reducing the Role of the Food, Tobacco, and Alcohol Industries in Noncommunicable Disease Risk in South Africa.
Delobelle P; Sanders D; Puoane T; Freudenberg N
Health Educ Behav; 2016 Apr; 43(1 Suppl):70S-81S. PubMed ID: 27037150
[TBL] [Abstract][Full Text] [Related]
31. Trade and investment liberalization and Asia's noncommunicable disease epidemic: a synthesis of data and existing literature.
Baker P; Kay A; Walls H
Global Health; 2014 Sep; 10():66. PubMed ID: 25213212
[TBL] [Abstract][Full Text] [Related]
32. International investment liberalization, transnational corporations and NCD prevention policy non-decisions: a realist review on the political economy of tobacco, alcohol and ultra-processed food.
Milsom P; Smith R; Baker P; Walls H
Global Health; 2021 Nov; 17(1):134. PubMed ID: 34819083
[TBL] [Abstract][Full Text] [Related]
33. Systems Thinking as a Framework for Analyzing Commercial Determinants of Health.
Knai C; Petticrew M; Mays N; Capewell S; Cassidy R; Cummins S; Eastmure E; Fafard P; Hawkins B; Jensen JD; Katikireddi SV; Mwatsama M; Orford J; Weishaar H
Milbank Q; 2018 Sep; 96(3):472-498. PubMed ID: 30277610
[TBL] [Abstract][Full Text] [Related]
34. [Health Promotion Policies for All in Taiwan].
Wang YW
Hu Li Za Zhi; 2018 Oct; 65(5):5-12. PubMed ID: 30276767
[TBL] [Abstract][Full Text] [Related]
35. India's NCD strategy in the SDG era: are there early signs of a paradigm shift?
Mondal S; Van Belle S
Global Health; 2018 Apr; 14(1):39. PubMed ID: 29695276
[TBL] [Abstract][Full Text] [Related]
36. Engaging with the Private Sector for Noncommunicable Disease Prevention and Control: Is it Possible to Create "Shared Value?".
Collins TE; Akselrod S; Mahy L; Poznyak V; Berlina D; Hatefi A; Allen L
Ann Glob Health; 2023; 89(1):46. PubMed ID: 37425141
[TBL] [Abstract][Full Text] [Related]
37. The role of causal ideas in the governance of commercial determinants of health. A qualitative study of tobacco control in the pacific.
Patay D; Schram A; Friel S
Soc Sci Med; 2022 Dec; 314():115481. PubMed ID: 36335703
[TBL] [Abstract][Full Text] [Related]
38. The dynamic of non-communicable disease control policy in Indonesia.
Christiani Y; Dugdale P; Tavener M; Byles JE
Aust Health Rev; 2017 May; 41(2):207-213. PubMed ID: 27209156
[TBL] [Abstract][Full Text] [Related]
39. Intersectoral policy on industries that produce unhealthy commodities: governing in a new era of the global economy?
Lencucha R; Thow AM
BMJ Glob Health; 2020 Aug; 5(8):. PubMed ID: 32816826
[TBL] [Abstract][Full Text] [Related]
40. On the verge of a chronic disease epidemic: comprehensive policies and actions are needed in Indonesia.
Kusuma D; Kusumawardani N; Ahsan A; K Sebayang S; Amir V; Ng N
Int Health; 2019 Nov; 11(6):422-424. PubMed ID: 31294789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
